| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Zenas Biopharma, Inc. (ZBIO) has 12 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. ZBIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.21M | $44.91M | - | |
| 10% | 1.17M | $23.86M | - | |
| Other | 500.0K | $10.16M | - | |
| Other | 175.0K | $3.56M | - | |
| Other | 150.0K | $3.05M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | Lu Hongbo59 | Director | Buy | 58,823 | $17.00 | $999,991.00 | New | -49.0% | +11.5% |